Ossur hf (OSSFF) Price & Analysis

Embla Medical hf, along with its various subsidiaries, is a global provider of non-invasive orthopedic solutions, serving markets across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. The company structures its business into three main divisions: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment delivers both conventional mechanical products for individuals with missing or differing upper and lower limbs, as well as advanced bionic technologies. These sophisticated bionic offerings encompass microprocessor-controlled feet, knees, hands, fingers, and specialized neuro orthotic joints. Through its Bracing and Supports division, Embla manufactures a variety of assistive devices, including support systems for the spine, hips, knees, feet, ankles, and hands. This segment also provides rehabilitation products for those recovering from fractures, undergoing post-operative care, or dealing with ligament injuries. Lastly, the Patient Care segment focuses on supplying prosthetic limbs for both upper and lower extremities, alongside orthotic devices designed to address neurological, gait-related, and musculoskeletal conditions. Embla Medical primarily caters to specialized medical institutions such as orthopedic and prosthetic clinics, hospitals, and surgical centers. Its products reach customers through a combination of direct sales teams and a network of distributors. Established in 1971, the company is headquartered in Reykjavik, Iceland. It previously operated under the name Össur hf until April 2024, when it officially became Embla Medical hf. The firm functions as a subsidiary of William Demant Invest A/S.